Company
olixpharma.com
Accelerate Drug Development using Oligonucleotides
Also known as OliX
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Customers
- pharma partners via joint R&D and license contracts
- Legal name
- 올릭스 주식회사
- olixpharma.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 17 September 2026
About
Olix Inc. is a company that develops new drugs for various diseases using asymmetric RNA interference (RNAi) technology.
Funding snapshot
- Latest round
- Undisclosed2026-06-01
Funding rounds
- Round, 2026
- 2026-06-01
Loading relationship preview